Where are pandemic influenza vaccines being produced?
Regulatory authorities have licensed (approved) pandemic vaccines in a number of countries. The length of the approval process depends on factors such as each country's regulatory pathway, the type of vaccine being licensed, and the stage of the manufacturer's readiness to submit appropriate information to regulatory authorities.
What is the global manufacturing capacity for pandemic influenza vaccines?
As of October, WHO estimates worldwide production capacity at about 3 billion doses per year in 12 months if all available capacity is devoted to pandemic vaccine.What technologies are being used to grow pandemic influenza viruses to make vaccines?
Most of these vaccines are being produced using chicken eggs, while a few manufacturers are using cell culture technology for vaccine production.Will there be enough pandemic influenza vaccine for everyone?
Production of the pandemic influenza vaccines continue but in some areas demand for vaccination is greater than the supply. This gap will narrow as more vaccines become available over time.Who will receive priority for vaccination?
WHO continues to recommend that health workers be given first priority for early vaccination to protect themselves and their patients, and help keep health systems functioning as the pandemic evolves.Other groups at higher risk for severe illness, based on clinical studies, should also be considered as priorities. National authorities will develop and implement vaccination plans based on circumstances within the country.
These other groups include pregnant women; those aged above 6 months with one of several chronic medical conditions; healthy young adults of 15 to 49 years of age; healthy children; healthy adults of 50 to 64 years of age; and healthy adults of 65 years of age and above.